Medical Management means using medications and other non-invasive therapies to treat disease and relieve symptoms. It’s exciting and historic that new treatments targeted for HCM are being studied and that the FDA approved Camzyos in 2022!
HCM can cause various symptoms depending on how stiff the heart is, how much scarring (fibrosis) there is, and whether there is obstruction. Some people have no noticeable symptoms. Symptoms of HCM may include chest pain/pressure, shortness of breath, lightheadedness, fatigue, palpitations, syncope (fainting)/near-syncope, and brain fog.
Medications are the first-line treatment for symptoms of HCM. If patients can’t tolerate one medicine, they can try another one in the same class or a medication from a different class. Here are some medications used to treat HCM and what they’re for:
To learn more and see the side effects of these medications, click HERE.
The post Medical Management May appeared first on Hypertrophic Cardiomyopathy Association.